Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift


Clinical studies of Parkinson’s disease (PD) using a dopamine cell replacment strategy have been tried for more than 30 years. The outcomes following transplantation of human fetal ventral mesencephalic tissue (hfVM) have been variable, with some patients coming off their anti-PD treatment for many years and others not responding and/or developing significant side effects, including graft-induced dyskinesia. This led to a re-appraisal of the best way to do such trials, which resulted in a new European-Union-funded allograft trial with fetal dopamine cells across several centers in Europe. This new trial, TRANSEURO (NCT01898390), is an open-label study in which some individuals in a large observational cohort of patients with mild PD who were undergoing identical assessments were randomly selected to receive transplants of hfVM. The TRANSEURO trial is currently ongoing as researchers have completed both recruitment into a large multicenter observational study of younger onset early-stage PD and transplantation of hfVM in 11 patients. While completion of TRANSEURO is not expected until 2021, we feel that sharing the rationale for the design of TRANSEURO, along with the lessons we have learned along the way, can help inform researchers and facilitate planning of transplants of dopamine-producing cells derived from human pluripotent stem cells for future clinical trials.


  • TRANSEURO consortium
  • Roger A. Barker
  • Krista Farrell
  • Natalie Valle Guzman
  • Xiaoling He
  • Stanley E. Lazic
  • Sarah Moore
  • Robert Morris
  • Pamela Tyers
  • Ruwani Wijeyekoon
  • Danielle Daft
  • Sam Hewitt
  • Viswas Dayal
  • Thomas Foltynie
  • Zinovia Kefalopoulou
  • Philipp Mahlknecht
  • Nick P. Lao-Kaim
  • Paola Piccini
  • Hjalmar Bjartmarz
  • Anders Björklund
  • Olle Lindvall
  • Jenny Nelander-Wahlestedt
  • Malin Parmar
  • Gesine Paul
  • Hakan Widner
  • Alistair Church
  • Stephen Dunnett
  • Kathryn Peall
  • Anne Rosser
  • Jean Marc Gurruchaga
  • Stéphane Palfi
  • Tobias Piroth
  • Christian Winkler
Enheter & grupper
Externa organisationer
  • University of Cambridge
  • Cardiff University
  • University College London
  • Imperial College London
  • Skåne University Hospital
  • Henri Mondor Hospital
  • Albert-Ludwigs University Freiburg
  • Addenbrooke's Hospital
  • The National Hospital for Neurology and Neurosurgery

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Neurovetenskaper
  • Hematologi
Sidor (från-till)1045–1053
Antal sidor9
TidskriftNature Medicine
StatusPublished - 2019 jul
Peer review utfördJa